Dr Absar Khalid Mir, Dr Mohammad Ahmad Abbasi, Dr Laiba Mustansar Sahi, Dr Samana Batool, Dr Muhammad Bilal Anwar, Dr Tehreem Ali, Dr Abeera Kazmi, Dr Israa Alam, & Dr Muhammad Ali Hassan. (2024). EVALUATING THE RISK-BENEFIT PROFILE OF RIVAROXABAN VERSUS WARFARIN IN STROKE PREVENTION AMONG ELDERLY PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION; A RETROSPECTIVE COHORT STUDY. Journal of Population Therapeutics and Clinical Pharmacology, 31(6), 1059-1065. https://doi.org/10.53555/jptcp.v31i6.6611